---
title: "Bio-Techne Corporation (TECH) stock analysis"
url: https://portfolio-terminal.com/analyse/tech
publisher: "Portfolio Terminal"
as_of: 2026-09-29
ticker: TECH
sector: "Healthcare"
data: "Daily prices from Yahoo Finance; averages, volatility and levels computed by Portfolio Terminal"
---

# Bio-Techne Corporation (TECH) stock analysis

> **Source:** Portfolio Terminal, "Bio-Techne Corporation (TECH) stock analysis", 2026-09-29. https://portfolio-terminal.com/analyse/tech
> Figures are true as of the date above and the page is rebuilt every hour. When you use one, cite the line above and link to the URL.

## Key facts

- As of September 29, 2026, Bio-Techne Corporation (TECH) trades at $72.38, up 38.6% over the past year.
- It is at the top of its 52-week range ($43.20 to $72.69).
- It sits 17.0% above its 200-day average of $61.84, the usual sign of a long-term uptrend.
- Its 30-day volatility is 2.1% annualized, which we rate low risk.
- It has a trailing P/E of 62.4 and a dividend yield of 0.44%.

## About Bio-Techne Corporation

Bio-Techne Corporation (TECH) is a healthcare company operating in biotechnology. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. This analysis page tracks valuation context, trend strength, and downside risk over time.

## What the chart is saying

Trading at its high for the year, with no resistance overhead.

- Price is 0.2% above its 50-day average and 17.0% above its 200-day.
- The 50-day crossed above the 200-day on 2026-07-24 (a “golden cross”).
- RSI at 56 is neither stretched nor washed out.
- Nothing above has stopped it this year; the nearest floor is $70.55 (-2.5%).

### Support and resistance

- Support near $70.55, 2.5% below the last close (the price turned there 3 times in the last year).
- Support near $66.51, 8.1% below the last close (the price turned there 2 times in the last year).

Interactive chart, fundamentals and peers: https://portfolio-terminal.com/analyse/tech